|
⚲
|
| Keyboard |
| Acuta Capital Partners LLC
✚
|
|
|---|---|
| CRD # | 158869 |
| SEC # | 801-136966 |
| CIK # | 0000158284, 0001582844 |
| AUM | 172.5 M (2026-06-30) |
| Employees | 4 (75% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 650-486-0508 |
| Address | 255 Shoreline Drive Redwood City, CA 94065 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0000158284 0001582844 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Praxis Precision Medicines Inc | 27.4 | ||
| Zeta Acquisition Corp II | 11.8 | ||
| BCTG Acquisition Corp | 9.2 | ||
| Bright Minds Biosciences Inc | 8.2 | ||
| Erasca Inc | 5.7 | ||
| Consonance-HFW Acquisition Corp | 5.0 | ||
| Ocular Therapeutix Inc | 5.0 | ||
| Olivia Ventures Inc | 4.5 | ||
| Minerva Neurosciences Inc | 4.3 | ||
| Helix Acquisition Corp | 3.6 | ||
| Argenx SE | 3.4 | ||
| Oculis Holding AG | 2.6 | ||
| Revolution Medicines Inc | 2.5 | ||
| Amylyx Pharmaceuticals Inc | 2.1 | ||
| Taysha Gene Therapies Inc | 2.0 | ||
| IDEAYA Biosciences Inc | 1.6 | ||
| Design Therapeutics Inc | 1.6 | ||
| United Therapeutics Corp | 1.3 | ||
| Entrada Therapeutics Inc | 1.1 | ||
| Cerecor Inc | 0.9 | ||
| LB Pharmaceuticals Inc | 0.7 | ||
| MAZE Therapeutics Inc | 0.6 | ||
| Unicycive Therapeutics Inc | 0.4 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Acuta Capital Fund LP | [2015-04-01] | 265.1 M | 130.3 M |
| Filed 2020-03-16 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Acuta Opportunity Fund LP | [2015-04-01] | 72.4 M | 42.3 M |
| Filed 2020-03-16 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| VC | Acuta Ventures LP | [2015-04-01] | 9.0 M | 64.4 M |
| Filed 2019-03-18 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 172.5 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 172.5 |
| By Discretionary | ||
| Discretionary | 3 | 172.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 172.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 2.1 | |
| United States Persons | 170.4 | |
| Total | 3 | 172.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Richard Lin | Executive Officer, Promoter | 25 | 3 | |
| Anupam Dalal | Executive Officer | 18 | 3 | |
| Manfred Yu | Executive Officer | 5 | 2 | |
| Longwood Capital Partners LLC | Promoter | 5 | 2 | |
| Acuta Capital Partners LLC | Promoter | 5 | 2 | |
| Longwood Capital Partners | Promoter | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001582844] | |
| SC 13D | [0001582844] | |
| SC 13G | [0001582844] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 254900E1CS9VUALU2O96 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Nine Left Capital LP
✚
|
NY | 176.1 M |
|
Three Bridges Capital LP
✚
|
NY | 175.5 M |
|
Teca Partners LP
✚
|
TX | 174.8 M |
|
Barington Companies Investors LLC
✚
|
NY | 172.9 M |
|
Counter Global LP
✚
|
CA | 172.7 M |
|
Nightview Capital LLC
✚
|
FL | 171.9 M |
|
Stillpoint Investments LP
✚
|
NY | 169.8 M |
|
Stone House Capital Management LLC
✚
|
FL | 169.8 M |
|
Baleen Capital Management LLC
✚
|
NV | 168.7 M |
|
Staines Financial LLC
✚
|
CA | 168.7 M |